Flatography: Detection of gastrointestinal diseases by faecal gas analysis.

Patients presenting with gastro-intestinal symptoms might suffer from a range of possible underlying diseases. An unmet need exists for novel cost-effective, reproducible, easy-to-perform and non-invasive tests. Hippocrates used body odours to diagnose diseases circa 460 before Christ. The art of diagnostic smelling is making a promising high-tech come-back with portable "electronic diagnostic noses". Analysis of faecal volatile organic compounds is a novel field in metabolomics with considerable potential to improve the diagnosis, phenotyping and monitoring of gastro-intestinal disease. Challenges will be to mature over the coming years by development of a standardized methodology for stool sample collection, storage, handling and analysis. Furthermore, key volatiles need to be identified to improve test accuracy and sensitivity by development of sensors tailored toward the accurate identification of disease specific volatiles. If these challenges are adequately faced, analysis of faecal volatiles has realistic potential to considerably improve screening, diagnosis and disease monitoring for gastro-intestinal diseases.

[1]  David S. Wishart,et al.  HMDB 3.0—The Human Metabolome Database in 2013 , 2012, Nucleic Acids Res..

[2]  J. Covington,et al.  Differentiating Coeliac Disease from Irritable Bowel Syndrome by Urinary Volatile Organic Compound Analysis – A Pilot Study , 2014, PloS one.

[3]  Ben Lacy Costello,et al.  The FASEB Journal • Research Communication Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease , 2022 .

[4]  B. Costello,et al.  The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva , 2014, Journal of breath research.

[5]  B. de Lacy Costello,et al.  A review of the volatiles from the healthy human body , 2014, Journal of breath research.

[6]  James A. Covington,et al.  A Novel Tool for Noninvasive Diagnosis and Tracking of Patients with Inflammatory Bowel Disease , 2013, Inflammatory bowel diseases.

[7]  Marc A Benninga,et al.  Faecal gas analysis by electronic nose as novel, non-invasive method for assessment of active and quiescent paediatric inflammatory bowel disease: Proof of principle study. , 2014, Journal of Crohn's & colitis.

[8]  H. Haick,et al.  Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors , 2010, British Journal of Cancer.

[9]  J. Covington,et al.  Evaluation of gut bacterial populations using an electronic e-nose and field asymmetric ion mobility spectrometry: further insights into ‘fermentonomics’ , 2012, Journal of medical engineering & technology.

[10]  N. Bârsan,et al.  Electronic nose: current status and future trends. , 2008, Chemical reviews.

[11]  J A Covington,et al.  Insights into ‘fermentonomics’: evaluation of volatile organic compounds (VOCs) in human disease using an electronic ‘e-nose’ , 2011, Journal of medical engineering & technology.

[12]  K. Persaud,et al.  Analysis of discrimination mechanisms in the mammalian olfactory system using a model nose , 1982, Nature.

[13]  Masoumeh Sikaroodi,et al.  Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[14]  C. Mulder,et al.  Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study , 2014, International journal of cancer.

[15]  R. Axel,et al.  A novel multigene family may encode odorant receptors: A molecular basis for odor recognition , 1991, Cell.